|
1
|
Adeva MM, Souto G, Blanco N and Donapetry
C: Ammonium metabolism in humans. Metabolism. 61:1495–1511. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wright G and Noiret L: OldeD amink SW and
Jalan R: Interorgan ammonia metabolism in liver failure: The basis
of current and future therapies. Liver Int. 31:163–175. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jones EA and Mullen KD: Theories of the
pathogenesis of hepatic encephalopathy. Clin Liver Dis. 16:7–26.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee WM: Acute liver failure. N Engl J Med.
329:1862–1872. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Blackmore L and Bernal W: Acute liver
failure. Clin Med. 15:468–472. 2015. View Article : Google Scholar
|
|
6
|
Butterworth RF: Hepatic encephalopathy:. A
central neuroinflammatory disorder? Hepatology. 53:1372–1376.
2011.PubMed/NCBI
|
|
7
|
Trautwein C and Koch A: Mechanisms of
acute liver failure. Liver Immunology. Gershwin MR, Vierling J and
Manns MP: (2nd). (New York, NY). Springer International Publishing.
373–388. 2014. View Article : Google Scholar
|
|
8
|
Mouli Pratap V, Benjamin J, Singh Bhushan
M, Mani K, Garg SK, Saraya A and Joshi YK: Effect of probiotic
VSL#3 in the treatment of minimal hepatic encephalopathy, A
non-inferiority randomized controlled trial. Hepatol Res.
45:880–889. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jover-Cobos M, Khetan V and Jalan R:
Treatment of hyperammonemia in liver failure. Curr Opin Clin Nutr
Metab Care. 17:105–110. 2014.PubMed/NCBI
|
|
10
|
Lange CM, Bojunga J, Hofmann WP, Wunder K,
Mihm U, Zeuzem S and Sarrazin C: Severe lactic acidosis during
treatment of chronic hepatitis B with entecavir in patients with
impaired liver function. Hepatology. 50:2001–2006. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fuhrmann V, Drolz A, Jaeger B, Wewalka M,
Saxa R, Horvatits T, Perkmann T, Zauner C and Ferenci P: Prognostic
relevance of arterial ammonia levels in different acute and
acute-on-chronic liver diseases. Crit Care. 16(Suppl 1): P3902012.
View Article : Google Scholar
|
|
12
|
Liu CP and Yu ZJ: Study on
L-Ornithine-L-Aspartate in the treatment of acute-on-chronic liver
failure. Zhonghua Gan Zang Bing Za Zhi. 19:63–64. 2011.(In
Chinese). PubMed/NCBI
|
|
13
|
Schmid M, Peck-Radosavljevic M, König F,
Mittermaier C, Gangl A and Ferenci P: A double-blind, randomized,
placebo-controlled trial of intravenous L-ornithine-L-aspartate on
postural control in patients with cirrhosis. Liver Int. 30:574–582.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu ZJ, Sun R, Liu XR, Yan JY, Gao XJ and
Kan QC: Hyperammonemia-induced hepatic injury in rats,
Characterization of a new animal model. Zhonghua Gan Zang Bing Za
Zhi. 21:467–472. 2013.(In Chinese). PubMed/NCBI
|
|
15
|
Li J, Yu Z, Wang Q, Li D, Jia B, Zhou Y,
Ye Y, Shen S, Wang Y, Li S, et al: Hyperammonia induces specific
liver injury through an intrinsic Ca2+-independent
apoptosis pathway. BMC Gastroenterol. 14:1512014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu Q, Gu L, Wang Y, Jia L, Zhao Z, Peng S
and Lei L: The role of alpha-1 and alpha-2 adrenoceptors in
restraint stress-induced liver injury in mice. PLoS One.
9:e921252014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bartek J and Lukas J: Mammalian G1- and
S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol.
13:738–747. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Myklebust MP, Li Z, Tran TH, Rui H,
Knudsen ES, Elsaleh H, Fluge Ø, Vonen B, Myrvold HE, Leh S, et al:
Expression of cyclin D1a and D1b as predictive factors for
treatment response in colorectal cancer. Br J Cancer.
107:1684–1691. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Esposti Degli D, Hamelin J, Bosselut N,
Saffroy R, Sebagh M, Pommier A, Martel C and Lemoine A:
Mitochondrial roles and cytoprotection in chronic liver injury.
Biochem Res Int. 2012:3876262012.PubMed/NCBI
|
|
20
|
Jalan R, Gines P, Olson JC, Mookerjee RP,
Moreau R, Garcia-Tsao G, Arroyo V and Kamath PS: Acute-on chronic
liver failure. J Hepatol. 57:1336–1348. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sarin SK, Kumar A, Almeida JA, Chawla YK,
Fan ST, Garg H, de Silva HJ, Hamid SS, Jalan R, Komolmit P, et al:
Acute-on-chronic liver failure: Consensus recommendations of the
Asian Pacific Association for the study of the liver (APASL).
Hepatol Int. 3:269–282. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Aldridge DR, Tranah EJ and Shawcross DL:
Pathogenesis of hepatic encephalopathy, Role of ammonia and
systemic inflammation. J Clin Exp Hepatol. 5((Suppl 1)): S7–S20.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bobermin LD, Quincozes-Santos A, Guerra
MC, Leite MC, Souza DO, Gonçalves CA and Gottfried C: Resveratrol
prevents ammonia toxicity in astroglial cells. PLoS One.
7:e521642012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rose CF: Ammonia: M ore than a neurotoxin?
Liver Int. 34:649–651. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Q, Wang Y, Yu Z, Li D, Jia B, Li J,
Guan K, Zhou Y, Chen Y and Kan Q: Ammonia-induced energy disorders
interfere with bilirubin metabolism in hepatocytes. Arch Biochem
Biophys 555-556. 16–22. 2014. View Article : Google Scholar
|
|
26
|
Zhang LJ, Qi R, Zhong J, Xu Q, Zheng G and
Lu GM: The effect of hepatic encephalopathy, hepatic failure, and
portosystemic shunt on brain volume of cirrhotic patients, A
voxel-based morphometry study. PLoS One. 7:e428242012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jia B, Yu ZJ, Duan ZF, Lü XQ, Li JJ, Liu
XR, Sun R, Gao XJ, Wang YF, Yan JY and Kan QC: Hyperammonaemia
induces hepatic injury with alteration of gene expression profiles.
Liver Int. 34:748–758. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Johnson DG and Walker CL: Cyclins and cell
cycle checkpoints. Annu Rev Pharmacol Toxicol. 39:295–312. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hartwell LH and Kastan MB: Cell cycle
control and cancer. Science. 266:1821–1828. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Stewart ZA, Mays D and Pietenpol JA:
Defective G1-S cell cycle checkpoint function sensitizes cells to
microtubule inhibitor-induced apoptosis. Cancer Res. 59:3831–3837.
1999.PubMed/NCBI
|
|
31
|
Chibazakura T, Kamachi K, Ohara M, Tane S,
Yoshikawa H and Roberts JM: Cyclin A promotes S-phase entry via
interaction with the replication licensing factor Mcm7. Mol Cell
Biol. 31:248–255. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kang DS, Hong K-M, Park J and Bae CD:
Cyclin A regulates a cell-cycle-dependent expression of CKAP2
through phosphorylation of Sp1. Biochem Biophys Res Commun.
420:822–827. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pardo FS, Su M and Borek C: Cyclin D1
induced apoptosis maintains the integrity of the G1/S checkpoint
following ionizing radiation irradiation. Somat Cell Mol Genet.
22:135–144. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ha SY, Kim HK, Im JS, Cho HY, Chung DH and
An J: Expression of Cyclin A, B1, D1, D3, and E in non-small lung
cancers. J Lung Cancer. 11:33–37. 2012. View Article : Google Scholar
|
|
35
|
Meng FJ, Jiao SM and Yu B: Picroside II
protects cardiomyocytes from hypoxia/reoxygenation-induced
apoptosis by activating the PI3K/Akt and CREB pathways. Int J Mol
Med. 30:263–270. 2012.PubMed/NCBI
|
|
36
|
Wu D, Jiang H, Chen S and Zhang H:
Inhibition of microRNA-101 attenuates hypoxia/reoxygenation-induced
apoptosis through induction of autophagy in H9c2 cardiomyocytes.
Mol Med Rep. 11:3988–3994. 2015.PubMed/NCBI
|
|
37
|
Hashimoto T, Yanaihara N, Okamoto A,
Nikaido T, Saito M, Takakura S, Yasuda M, Sasaki H, Ochiai K and
Tanaka T: Cyclin D1 predicts the prognosis of advanced serous
ovarian cancer. Exp Ther Med. 2:213–219. 2011.PubMed/NCBI
|
|
38
|
Pontano LL and Diehl JA: Speeding through
cell cycle roadblocks: Nuclear cyclin D1-dependent kinase and
neoplastic transformation. Cell Div. 3:122008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Peurala E, Koivunen P, Haapasaari KM,
Bloigu R and Jukkola-Vuorinen A: The prognostic significance and
value of cyclin D1, CDK4 and p16 in human breast cancer. Breast
Cancer Res. 15:R52013. View
Article : Google Scholar : PubMed/NCBI
|
